Michael Fedorov
Papers
1
Total Citations
9
H-Index
1
About
Michael Fedorov is a leading figure in the field of stereotactic body radiation therapy (SBRT), with a particular focus on the use of robotic radiosurgery for treating oligometastatic disease. His most cited work, "Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases" (2018, 9 citations), provides critical long-term efficacy data for the CyberKnife system in managing liver metastases. This study directly addresses a key gap in the literature, offering evidence that robotic radiosurgery can achieve durable survival outcomes comparable to surgical resection in select patients. Fedorov’s contributions are foundational to establishing non-invasive, high-precision radiotherapy as a standard option for liver-confined metastatic cancer. His research is instrumental in helping clinicians weigh the risks and benefits of local ablative therapies versus traditional surgery, ultimately expanding treatment possibilities for patients who are not surgical candidates. Through his work, Fedorov has helped define the modern role of radiosurgery in multidisciplinary oncology, making him a respected voice in the advancement of image-guided radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1